Literature DB >> 25001971

Neurogastroenterology: Neuronal correlates of placebo in chronic FGIDs.

QiQi Zhou1, G Nicholas Verne1.   

Abstract

Placebo analgesia is increasingly appreciated in many difficult to treat chronic functional gastrointestinal disorders such as IBS. However, investigations of interactions between psychological and biological placebo factors are still in early stages. Now, technologies have been developed that enable neural mechanisms of placebo analgesia to be studied more directly in humans.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25001971      PMCID： PMC5690476          DOI： 10.1038/nrgastro.2014.118

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


  10 in total

1.  Placebo and opioid analgesia-- imaging a shared neuronal network.

Authors:  Predrag Petrovic; Eija Kalso; Karl Magnus Petersson; Martin Ingvar
Journal:  Science       Date:  2002-02-07       Impact factor: 47.728

Review 2.  Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment.

Authors:  A Hróbjartsson; P C Gøtzsche
Journal:  N Engl J Med       Date:  2001-05-24       Impact factor: 91.245

Review 3.  The brain-gut axis in abdominal pain syndromes.

Authors:  Emeran A Mayer; Kirsten Tillisch
Journal:  Annu Rev Med       Date:  2011       Impact factor: 13.739

Review 4.  New insights into visceral hypersensitivity--clinical implications in IBS.

Authors:  QiQi Zhou; G Nicholas Verne
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-06       Impact factor: 46.802

5.  Regional mu opioid receptor regulation of sensory and affective dimensions of pain.

Authors:  J K Zubieta; Y R Smith; J A Bueller; Y Xu; M R Kilbourn; D M Jewett; C R Meyer; R A Koeppe; C S Stohler
Journal:  Science       Date:  2001-07-13       Impact factor: 47.728

6.  Enhanced affect/cognition-related brain responses during visceral placebo analgesia in irritable bowel syndrome patients.

Authors:  Hsing-Feng Lee; Jen-Chuen Hsieh; Ching-Liang Lu; Tzu-Chen Yeh; Cheng-Hao Tu; Chou-Ming Cheng; David M Niddam; Han-Chieh Lin; Fa-Yauh Lee; Full-Young Chang
Journal:  Pain       Date:  2012-04-27       Impact factor: 6.961

7.  Central and peripheral hypersensitivity in the irritable bowel syndrome.

Authors:  QiQi Zhou; Roger B Fillingim; Joseph L Riley; William B Malarkey; G Nicholas Verne
Journal:  Pain       Date:  2010-01-13       Impact factor: 6.961

Review 8.  Widespread hyperalgesia in irritable bowel syndrome is dynamically maintained by tonic visceral impulse input and placebo/nocebo factors: evidence from human psychophysics, animal models, and neuroimaging.

Authors:  Donald D Price; Jason G Craggs; QiQi Zhou; G Nicholas Verne; William M Perlstein; Michael E Robinson
Journal:  Neuroimage       Date:  2009-04-16       Impact factor: 6.556

9.  Diffusion tensor imaging detects microstructural reorganization in the brain associated with chronic irritable bowel syndrome.

Authors:  Benjamin M Ellingson; Emeran Mayer; Robert J Harris; Cody Ashe-McNally; Bruce D Naliboff; Jennifer S Labus; Kirsten Tillisch
Journal:  Pain       Date:  2013-04-08       Impact factor: 6.961

10.  Placebo analgesia in patients with functional and organic abdominal pain: a fMRI study in IBS, UC and healthy volunteers.

Authors:  Julia Schmid; Jost Langhorst; Florian Gaß; Nina Theysohn; Sven Benson; Harald Engler; Elke R Gizewski; Michael Forsting; Sigrid Elsenbruch
Journal:  Gut       Date:  2014-05-15       Impact factor: 23.059
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.